- 1. A Disintegrin and Metalloprotease with Thrombospondin Motifs-1
- [A disintegrin and metalloproteinase with thrombospondin motifs-1 (ADAMTS-1), encoded by the ADAMTS1 gene is a member of the ADAMTS protein family. It cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. It has anti-angiogenic activity and inhibits endothelial cell proliferation. ADAMTS1 may be associated with various inflammatory processes as well as development of cancer cachexia. It is likely to be necessary for normal growth, fertility, and organ morphology and function. ADAMTS1 is secreted and associated with the extracellular matrix. The Spacer Domain and the TSP Type-1 Domains are important for a tight interaction with the extracellular matrix. ADAMTS1 is expressed as a 110-kD protein, an 85-kD protein after cleavage at the subtilisin site, or as a 67-kD protein, which is most abundant, generated by an additional processing event. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1307941) A Disintegrin And Metalloproteinase With Thrombospondin Motifs 1;
ADAMTS1;
ADAM-TS1;
METH-1 =Amino Acid, Peptide, or Protein; Enzyme | - 12. Adipiodone, Dimeglumine Salt
- [The meglumine salt form of iodipamide, a triiodinated benzoate derivative, and an ionic dimeric contrast agent used in diagnostic imaging. When administered in vivo, iodipamide is removed from the liver and secreted into the biliary tract. Like other organic iodine compounds, this agent blocks x-ray and appears opaque on x-ray film; thereby enhancing the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures. ( NCI )] (UMLS (NCI) C0065885) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IODIPAMIDE;
=IODIPAMIDE MEGLUMINE 26.8 %;
IODIPAMIDE MEGLUMINE 52 %;
IODIPAMIDE MEGLUMINE 10.3 %;
|
- 2. A Disintegrin and Metalloprotease with Thrombospondin Motifs-9
- [A disintegrin and metalloproteinase with thrombospondin motifs-9 (ADAMTS9), encoded by the ADAMTS9 gene, is a member of the ADAMTS protein family. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. This enzyme contains four C-terminal TS motifs. The spacer domain and the TSP Type-1 domains are important for a tight interaction with the extracellular matrix. The precursor is cleaved by a furin endopeptidase. Two isoforms, a long form and a short form, may be produced by alternative splicing. ADAMTS9 is secreted and associated with the extracellular matrix. It is highly expressed in all fetal tissues and expressed slightly in adult ovary, pancreas, heart, kidney, lung, placenta, spinal cord and brain. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1257533) A Disintegrin and Metalloproteinase with Thrombospondin Motifs-9;
ADAMTS9;
ADAM-TS9 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 13. adipocyte
- [fat-storing cells found mostly in the abdominal cavity and subcutaneous tissue. ( CSP )] (UMLS (CSP) C0206131) =Cell ;
=adipose fat body;
Connective and Soft Tissue Cell |
- 3. A Disintegrin and Metalloproteinase Domain 11 Gene
- [This gene plays a role in cell-cell and cell-matrix interactions. ( NCI )] (UMLS (NCI) C1332015) ADAM11;
ADAM11 Gene;
=Gene or Genome ;
| - 14. Adipocyte with Nuclear Atypia
- (UMLS (NCI) C1510808) =Cell
|
- 4. A Disintegrin and Metalloproteinase Domain 11 Protein
- [This protein is a member of the ADAM protein family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The gene represents a candidate tumor supressor gene for human breast cancer based on its location within a minimal region of chromosome 17q21 previously defined by tumor deletion mapping. (LocusLink) ( NCI )] (UMLS (NCI) C1332016) ADAM11;
ADAM11 Protein;
Metalloproteinase-Like, Disintegrin-Like and Cysteine-Rich Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 15. adipogenesis
- [The production of fat, either fatty degeneration or fatty infiltration; also applied to the normal deposition of fat or to the conversion of carbohydrate or protein to fat. ( NCI )] (UMLS (CSP) C0596843) =Molecular Function
|
- 5. A Disintegrin and Metalloproteinase Domain 15
- [MDC-15; ADAM-15; metargidin. Member of a sequence-related family of cysteine-rich membrane proteins containing metalloproteinase-like and disintegrin-like domains; contains an RGD sequence in its disintegrin domain. ( NCI )] (UMLS (NCI) C1313290) ADAM15;
EC 3.4.24.-;
MDC15;
Metalloprotease-RGD-Disintegrin Protein;
Metalloproteinase-Like Disintegrin-Like and Cysteine-Rich Protein 15;
Metargidin =Amino Acid, Peptide, or Protein; Enzyme ;
| - 16. Adipogenesis Inhibitory Factor
- [cloned from a primate stromal cell line; plays a role in megakaryocyte proliferation and B cell differentiation. ( CSP )] (UMLS (NCI) C0083031) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=Cytokine;
|
- 6. A Disintegrin and Metalloproteinase Domain 15 Gene
- [This gene is involved in the restructuring of the mesangial matrix. ( NCI )] (UMLS (NCI) C1332017) ADAM15;
ADAM15 Gene;
=Gene or Genome ;
| - 17. Adipogenesis Inhibitory Factor
- [(in-ter-LOO-kin) IL-11. A type of biological response modifier (a substance that can improve the body's natural response to infection and disease) that stimulates immune response and may reduce toxicity to the gastrointestinal system resulting from cancer therapy. These substances are normally produced by the body. They are also made in the laboratory for use in treating cancer and other diseases. Also called oprelvekin. ( NCI )] (UMLS (NCI) C0537670) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Recombinant Protein;
[BL400] BLOOD FORMATION PRODUCTS =OPRELVEKIN 5 MG |
- 7. A Disintegrin and Metalloproteinase Domain 17 (Tumor Necrosis Factor, Alpha, Converting Enzyme) Gene
- [This gene plays a role in the cleavage of membrane proteins, resulting in the release of their extracellular domains from cells. ( NCI )] (UMLS (NCI) C1412186) ADAM17;
ADAM17 Gene =Gene or Genome ;
| - 18. adiponectin
- [peptide hormone produced by adipocytes, involved in glucose and lipid regulation. ( CSP )] (UMLS (CSP) C0389071) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Peptide Hormone;
|
- 8. A Disintegrin-Like and Metalloprotease (Reprolysin Type) with Thrombospondin Type 1 Motif, 1 Gene
- [This gene is involved in the inhibition of angiogenesis and cell proliferation. ( NCI )] (UMLS (NCI) C1332018) ADAMTS1;
ADAMTS1 Gene;
=Gene or Genome ;
| - 19. adipose fat body
- [connective tissue composed of fat cells lodged in the meshes of areolar tissue. ( CSP )] (UMLS (CSP) C0001527) =Tissue ;
|
- 9. A Disintegrin-Like and Metalloprotease (Reprolysin Type) with Thrombospondin Type 1 Motif, 9 Gene
- [This gene plays a role in apoptosis and development. ( NCI )] (UMLS (NCI) C1332020) ADAMTS9;
ADAMTS9 Gene;
=Gene or Genome ;
| - 20. Adipose Tissue Neoplasm
- [A benign or malignant tumor composed of adipose (fatty) tissue. — 2003 ( NCI )] (UMLS (NCI) C0206631) =Neoplastic Process =Connective and Soft Tissue Neoplasm;
=AZALEKO LIPOMA;
Liposarcoma;
Angiolipoma;
Angiomyolipoma;
Adrenal Gland Myelolipoma |
- 10. Adiaphoresis
- (UMLS (NCI) C0003028) =Disease or Syndrome ;
| - 21. adiposity
- [The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status. ( MSH )] (UMLS (CSP) C1563743) =Organism Attribute; ;
|
- 11. adipex P
- [ ] (UMLS (CSP) C0001520) =Organic Chemical; Pharmacologic Substance
| - 22. adipsia
- [ ] (UMLS (CSP) C0277967) =Sign or Symptom
|
home
